Eplerenone
اپلرنون
❤️ Cardiovascular SystemMineralocorticoid receptor antagonist
Market / country: 🇺🇸 USA
Inspra (US)
🧮 Dose calculator
Heart failure · Regimen source: FDA Eplerenone · 2.1
- • Adjust by serum potassium per label Table 1. Check potassium before starting and periodically. FDA Eplerenone · 2.1FDA Eplerenone · 2.3
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ All patients: K >5.5 at start; CrCl ≤30; strong CYP3A inhibitors. FDA Eplerenone · 4
- ⛔ Hypertension: type 2 diabetes with microalbuminuria; creatinine >2.0 (men) or >1.8 (women); CrCl <50; potassium supplements or potassium-sparing diuretics. FDA Eplerenone · 4
Formulations
- 25 mg tablet — tablet 🇺🇸 USA FDA Eplerenone · 3
- 50 mg tablet — tablet 🇺🇸 USA FDA Eplerenone · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Eplerenone · 8.1
“Risk Summary The available data from published case reports on eplerenone use during pregnancy are insufficient to establish a drug-associated risk of major birth defects, miscarriage, adverse maternal or fetal outcomes (see Clinical Considerations ) .”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Eplerenone · 8.2
“Risk Summary There are no human data available on whether eplerenone is present in human milk, or has effects on breastfed infants or on milk production.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Eplerenone · 8.4
“The safety and effectiveness of eplerenone for treatment of hypertension have not been established in pediatric patients.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Eplerenone · 8.5
“However, due to age-related decreases in creatinine clearance, the incidence of laboratory-documented hyperkalemia was increased in patients 65 and older [see Warnings and Precautions (5.1) ] .”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Eplerenone · 8.3
“Infertility Based on animal data, use of eplerenone may compromise male fertility.”
🔗 Reference links
- FDA (approval record)ANDA208283
- DailyMed (FDA label)FDA Eplerenone
- MedlinePlus (NIH)Eplerenone
- WHO ATC/DDDC03DA04
- Darooyab (Iran)Eplerenone
🇮🇷 Registered in Iran Darooyab · G-1664/Eplerenone
Dosage forms with Iranian generic codes, per Darooyab.
- 09626 · EPLERENONE 25MG TAB · قرص اپلرنون ۲۵ میلیگرم
- 09644 · EPLERENONE 50MG TAB · قرص اپلرنون ۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Eplerenone · 3FDA Eplerenone · 2.1FDA Eplerenone · 2.3FDA Eplerenone · 2.2FDA Eplerenone · 4FDA Eplerenone · 8.1FDA Eplerenone · 8.2FDA Eplerenone · 8.4FDA Eplerenone · 8.5FDA Eplerenone · 8.3FDA Eplerenone · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1664/Eplerenone
- Clinical review⚠ Unverified